EvaluatePharma - Abbott Laboratories - Worldwide

Abbott Laboratories

All Financial Data in US $ (mln)

Worldwide

Overview

Company News

Abbott Completes Acquisition of Piramal's Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India
Abbott Laboratories (September 08, 2010)

Event - Meridia adcom debate primes pump for Lorqess decision

(September 03, 2010)

Abbott Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment
Abbott Laboratories (September 01, 2010)

CORDIS Announces Results of Ten-year CYPHER® Sirolimus-eluting Coronary Stent Follow-up
Johnson & Johnson (August 31, 2010)

Abbott Japan And Eisai Submit Application For Additional Indication Of Humira®, A Fully Human Anti-TNF Monoclonal Antibody, For The Treatment Of Juvenile Idiopathic Arthritis In Japan
Eisai (August 30, 2010)

Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
Abbott Laboratories (August 30, 2010)

Abbott Provides Initial Support for Flood Relief Efforts in Pakistan
Abbott Laboratories (August 25, 2010)

Advanced Life Sciences Sees Funding Opportunity for Restanza in New HHS Medical Countermeasure Report
Advanced Life Sciences (August 24, 2010)

SkyePharma Regains United States Marketing Rights to Flutiform(™)
SkyePharma (August 20, 2010)

Abbott Launches New Psoriasisanswers.com Web site
Abbott Laboratories (August 12, 2010)

Displaying 10 out of a possible 2065 unique stories.
Results Sorted By date
Display All Stories

EvaluatePharma® - the premier source for pharma and biotech analysis.

Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status, deals, license revenues and much more.

Company Profile



Profile	Abbott Laboratories (ABT) is an Illinois based global pharmaceutical & medical device company focused on development of pharmaceuticals and medical products including nutritionals, devices and diagnostics.
Listed or Private Company	Listed
Company Classification	Global Majors; Med Tech
Company Website	Website

Full Company Profile Information

EventAnalyzer - Last Key Event


Closing Price DateClosing Price Date	EventAnalyzer Note	Market Cap (US $m)	Change (%)	Change (+$m)
7/21/2010	21 Jul: Company reports higher-than-expected Q2 results helped by strong sales growth for all of its key units, and higher international sales from its recently acquired Solvay division. Standard & Poor's maintains its "buy" rating.	75,141	2.5%	1,868

Top 3 Products (Worldwide Sales 2007/08)

				Annual Sales WW - Sales		Growth per Year (%)
Rank¹	Product	Generic Name	Therapeutic Subcategory	2007	2008	2008
1	Humira	adalimumab	Other anti-rheumatics	3,064²	4,521³	+48%
2	Kaletra	lopinavir & ritonavir	Anti-virals	1,325⁴	1,474⁵	+11%
3	Depakote	divalproex sodium	Anti-epileptics	1,575⁶	1,364⁷	-13%

Note: Shaded Cells⁸

RX Sales Chart

Abbott Laboratories	Data		Growth
	2007	2008	2008
Revenues By Segment
Pharmaceuticals
Pharmaceuticals Sales (In-depth)
Rx & OTC Pharmaceuticals
Prescription (Rx) Pharmaceuticals	16,133⁹	17,124¹⁰	+6%

Therapy Area Focus in 2008

Abbott Laboratories
	2008
WW Rx & OTC Sales By Therapy Area
Main Categories
Cardiovascular	2,785
Central Nervous System	2,151
Endocrine	1,157
Gastro-Intestinal	462
Genito-Urinary	56
Musculoskeletal	4,521
Oncology & Immunomodulators	695
Respiratory	149
Systemic Anti-Infectives	2,923
Other Rx & OTC Pharma	2,223¹¹

EvaluatePharma® Coverage of Marketed and Pipeline Products


	Product Count
Abbott Laboratories ¹²	449

IN-DEPTH COMPETITIVE INTELLIGENCE AVAILABLE ON


	Product	Generic Name
Abbott Laboratories	5-HT1A Agonist Program	-
	5HT5 Receptor Research Program	-
	A-348441	-
	A-352086	-
	Abbokinase	urokinase
	Abbott Vitamins/Hematinics	multivitamin
	Abbott/Raven Oncology MAb	-
	ABS-103	(R)-valproate sodium
	ABT-072	-
	ABT-089	pozanicline
	ABT-100	-
	ABT-102	-
	ABT-107	-
	ABT-126	-
	ABT-127	-
	ABT-164	-
	ABT-202	-
	ABT-210	-
	ABT-224	-
	ABT-229	alemcinal
	ABT-239	-
	ABT-263	navitoclax
	ABT-279	-
	ABT-281	ascrolimus
	ABT-288	-
	ABT-308	-
	ABT-325	-
	ABT-333	-
	ABT-384	-
	ABT-431	adrogolide
	ABT-450	-
	ABT-492	delafloxacin
	ABT-510	-
	ABT-518	-
	ABT-546	-
	ABT-560	-
	ABT-567	-
	ABT-594	tebanicline tosylate
	ABT-598	-
	ABT-606	valomaciclovir
	ABT-670	-
	ABT-724	-
	ABT-737	-
	ABT-751	-
	ABT-769	-
	ABT-828	-
	ABT-834	-
	ABT-869	linifanib
	ABT-874	briakinumab
	ABT-888	veliparib
	ABT-894	sofinicline
	ABT-925	-
	ABT-963	-
	ABT-980	fiduxosin
	Aceon	perindopril erbumine
	Actiq	fentanyl citrate
	Actos	pioglitazone hydrochloride
	Advicor	lovastatin & niacin
	Akineton	biperiden hydrochloride
	AKT inhibitor	-
	Alibra	alprostadil & prazosin
	Almogran	almotriptan maleate
	Amidate	etomidate
	Amiodarone	amiodarone hydrochloride
	Amitiza	lubiprostone
	Anadrol-50	oxymetholone
	Anatibant	anatibant
	AndroGel	testosterone
	Antibody 806	-
	Anti-IL18 MAb Research Project	-
	Anti-inflammatory monoclonal antibody	-
	Anti-TMEFF2 MAb-drug conjugate	-
	Anzemet	dolasetron mesylate
	ARI-1778	-
	Asoprisnil	asoprisnil
	Atracurium	atracurium besylate
	Avonex	interferon beta-1a
	Azmacort	triamcinolone acetonide
	Bareon	lomefloxacin hydrochloride
	Betaserc/Serc	betahistine hydrochloride
	Biaxin XL	clarithromycin
	Biaxin/Klacid	clarithromycin
	Bifiteral/Duphalac	lactulose
	Bimoclomol	bimoclomol
	Bioabsorbable Drug-Eluting Stent	everolimus
	Blink Contacts	electrolytes & hyaluronate
	Blink Tears	polyethylene glycol
	Blopress	candesartan cilexetil
	BMS-901608	elotuzumab
	Bremax	tulobuterol hydrochloride
	Brufen/Motrin	ibuprofen
	BSF 201640 (DTA 201)	-
	BSF 302146	-
	BSF 74681	-
	BSF 78438	-
	Bupivacaine	bupivacaine hydrochloride
	Butamben	butamben
	Butorphanol	butorphanol tartrate
	Calcijex	calcitriol
	Calmactin	cilansetron
	Cancer antibodies	-
	Cancer small molecule drugs	-
	Cancer Vaccine	-
	Cardene IV Pre-mixed bag	nicardipine hydrochloride
	Cardizem LA	diltiazem hydrochloride
	Cartrol	carteolol hydrochloride
	Cefditoren	cefditoren pivoxil
	Cell adhesion inhibitor	-
	Cenestin	estrogens (conjugated)
	Cerebrolysin	cerebrolysin
	Certiva	DTPa vaccine
	Certriad	choline fenofibrate & rosuvastatin calcium
	Chemotaxis inhibitor	-
	Chirocaine	levobupivacaine hydrochloride
	Chk1 inhibitor	-
	Chrysalin	rusalatide acetate
	Chymodiactin	chymopapain
	Claforan	cefotaxime sodium
	Clavulin	amoxicillin & clavulanate potassium
	Clindamycin Phosphate	clindamycin phosphate
	Clivarine	reviparine sodium
	Coactinon	emivirine
	Corlopam	fenoldopam mesylate
	Co-stimulation inhibitor	-
	COT-kinase inhibitor	-
	Coviracil (Emtriva)	emtricitabine
	Cranoc	fluvastatin sodium
	Creon	pancrelipase
	Crestor	rosuvastatin calcium
	Cryptaz	nitazoxanide
	CV Immune modulators	-
	Cylert	pemoline
	Cytokine inhibitor	-
	Cytotect	cytomegalovirus (CMV) immune globulin
	D2/3-Antagonist	-
	D3 antagonist	-
	D4 agonist	-
	Daclizumab	daclizumab
	DAPD	amdoxovir
	Darusentan	darusentan
	Demerol	meperidine hydrochloride
	Depacon	valproate sodium
	Depakene	valproic acid
	Depakote	divalproex sodium
	Depakote ER	divalproex sodium
	Desoxyn	methamphetamine hydrochloride
	Dicetel	pinaverine
	Digoxin	digoxin
	Dilaudid	hydromorphone hydrochloride
	Diltiazem	diltiazem hydrochloride
	DM-1796	gabapentin
	Domantis Inflammation Research Project	-
	Dopamin	dopamine hydrochloride
	Duodopa	carbidopa & levodopa
	Duphaston	dydrogesterone
	Duspatal/Colofac	mebeverine hydrochloride
	EchoGen	perflenapent
	Effexor XR	venlafaxine hydrochloride
	Elagolix (NBI-56418)	elagolix
	E-mycin	erythromycin
	Endeavour Drug-Eluting Coronary Stent	zotarolimus
	Ensure Liquid	inulin & omega-3 acid ethyl esters
	Erythrocin	erythromycin stearate
	Esberiven	coumarin & rutin
	ESP 305	ularitide
	Estratab	estrogens (esterified)
	Ethrane	enflurane
	Exelon	rivastigmine hydrogen tartrate
	Factive	gemifloxacin mesylate
	FATP4	-
	Femoston	17-beta estradiol & dydrogesterone
	Fentanyl	fentanyl citrate
	Firazyr	icatibant
	Flamexin	piroxicam
	Flomax	tamsulosin hydrochloride
	Flutiform	fluticasone propionate & formoterol fumarate
	Forane	isoflurane
	Fosrenol	lanthanum carbonate
	Froben/Ansaid	flurbiprofen
	Furosemide	furosemide
	Gabitril	tiagabine
	Ganaton	itopride hydrochloride
	Gengraf	cyclosporine
	Gentamicin Sulfate	gentamicin sulfate
	Glucocorticoid Agonists	-
	Grippol TC	influenza vaccine
	GTST Program	-
	h224G11	-
	H5N1 mono vaccine	avian (H5N1) influenza vaccine
	HBI-3000	-
	H-BIG	hepatitis B immune globulin (human)
	HCV Polymerase Program	-
	HCV protease inhibitor	-
	Heparin Sodium	heparin sodium
	Hextend	hetastarch
	HIV-IG	-
	Hokunalin Tape	tulobuterol hydrochloride
	HSR 609	-
	HSR 81	meluadrine tartrate
	HSR 903	olamufloxacin
	HuM195-Ac-225	-
	HuM195-Bi-213	-
	Humira	adalimumab
	Hypoca	barnidipine hydrochloride
	Hytrin	terazosin hydrochloride
	ICS/LABA (KI03219)	-
	Ilaprazole	ilaprazole
	Imudon	lyophilized bacterial lysates
	Influvac	influenza vaccine
	Inhibace	cilazapril
	Intranasal Influenza vaccine	influenza vaccine
	Invivac	influenza vaccine
	Iopamidol	iopamidol
	Iron oligosaccaride	-
	IRS 19	bacterial lysate
	Isoptin	verapamil
	J 956	asoprisnil ecamate
	Jurnista	hydromorphone hydrochloride
	Kaletra	lopinavir & ritonavir
	Ketorolac Tromethamine	ketorolac tromethamine
	KH01500	-
	KH01501	-
	KH01502	-
	KI03218	-
	KI04204	-
	Klonopin Wafers	clonazepam
	KS 01-017	-
	KS 02 212	insulin
	KS 04 208	-
	K-Tab	potassium chloride
	Labetalol	labetalol hydrochloride
	Lck kinase inhibitor	-
	Letairis/Volibris	ambrisentan
	Levophed	norepinephrine bitartrate
	Lexapro	escitalopram oxalate
	LF231591	-
	LF242594	-
	LF246691	-
	LF250033	-
	L-FMAU	clevudine
	LGD2226	-
	LGD-2941	-
	LGD-3129	-
	LGD-3303	-
	Lialda	mesalamine
	Lidocaine	lidocaine
	Loftyl	buflomedil hydrochloride
	Lomexin/Gynoxin	fenticonazole mononitrate
	Long acting bupivacaine	bupivacaine hydrochloride
	Lorazepam	lorazepam
	LPCN 1021	testosterone
	Lung cancer antibody	-
	Lupron	leuprolide acetate
	Lupron Depot	leuprolide acetate
	Luvox	fluvoxamine maleate
	Luvox CR	fluvoxamine maleate
	M200	volociximab
	Magnesium sulphate IV	magnesium sulfate
	Magnevist	gadopentetate dimeglumine
	Mannitol	mannitol
	Marinol	dronabinol
	Marinol (inhaled)	dronabinol
	Mavik/Gopten/Odrik	trandolapril
	Maxaquin	lomefloxacin hydrochloride
	Mediatensyl	urapidil hydrochloride
	Mepivacaine	mepivacaine hydrochloride
	Meridia/Reductil	sibutramine hydrochloride
	MetAP2 inhibitor	-
	Metoclopramide	metoclopramide hydrochloride
	Micardis	telmisartan
	Micardis HCT	hydrochlorothiazide & telmisartan
	Micropump Lansoprazole	lansoprazole
	Midazolam	midazolam hydrochloride
	Mivacron	mivacurium chloride
	MLN4760	-
	Mobic	meloxicam
	Morphine	morphine sulfate
	MUSE	alprostadil
	NA channel	-
	Nembutal	pentobarbital
	NeoProfen	ibuprofen lysine
	Neosaldina	caffeine, isometheptene & sulpyrine
	Neuropathic Pain Research Project	-
	Next Generation cMet MAb	-
	Next Generation Drug-Eluting Stent	zotarolimus & dexamethasone
	Niaspan	niacin
	Niaspan/ASA	aspirin & niacin
	Nimbex	cisatracurium besylate
	Norvir	ritonavir
	Novel protease inhibitor	-
	Novel ribosome inhibitor	-
	NovoNorm/Prandin	repaglinide
	NPS-1776	isovaleramide
	NS-49 (ABT-232)	-
	NSD-683	-
	NSD-686	-
	Numax	motavizumab
	Nuromax	doxacurium chloride
	Nyotran	nystatin
	Oesclim/Esclim	estradiol
	Ogen	estropipate
	Omacor	omega-3 acid ethyl esters
	Omnicef	cefdinir
	Omniflox	temafloxacin
	Oncology Research Program	-
	Oncology RNAi therapeutic	-
	Open-Cath-R (r-UK)	urokinase
	Oral thrombin inhibitor	-
	Orathecin	rubitecan
	Oxandrin	oxandrolone
	OxyContin	oxycodone hydrochloride
	P2X	-
	Paclitaxel	paclitaxel
	Panhematin	hemin
	Panzytrat	pancrelipase
	Pardoprunox (SLV 308)	pardoprunox
	PCE	erythromycin
	PDL192	-
	PDL241	-
	PDL252	-
	Pediazole	erythromycin ethylsuccinate & sulfisoxazole
	Peganone	ethotoin
	Pemtumomab	pemtumomab
	PG110	-
	Phlebodia	diosmin
	Physiotens	moxonidine
	Polyful	polycarbophil calcium
	Precedex	dexmedetomidine hydrochloride
	Prefolic	leucovorin calcium
	Pre-Par	ritodrine hydrochloride
	Presomen	estrogens (conjugated)
	Presomen Combi	estrogens (conjugated) & medrogestone
	Prevacid	lansoprazole
	PRO 140	-
	Proheparum	bovine liver hydrolysate
	Prolyse	nasaruplase
	Prometrium	progesterone
	ProSom	estazolam
	Prothiaden	dothiepin hydrochloride
	PTP1B program	-
	Pulzium	tedisamil
	Quinolone 1	-
	Quinolone Research Program	-
	Raniplex	ranitidine hydrochloride
	Restanza	cethromycin
	Riquent	abetimus sodium
	Rondec	carbinoxamine maleate & pseudoephedrine hydrochloride
	Rowasa	mesalamine
	Rythmol	propafenone hydrochloride
	SangCya (Oral Solution)	cyclosporine
	Santyl	collagenase
	Segard	afelimomab
	Selsun Blue	selenium sulfide
	Serlect	sertindole
	Sevorane/Ultane	sevoflurane
	SGN-33	lintuzumab
	Sialor	anethole trithione
	Signal transduction inhibitor	-
	Simcor	niacin & simvastatin
	Simdax	levosimendan
	SLV 316	-
	SLV 320	-
	SLV 326	-
	SLV 329	-
	SLV 330	-
	SLV 332	-
	SLV 333	-
	SLV 334	-
	SLV 335	-
	SLV 337	-
	SLV 338	-
	SLV 341	-
	SLV 342	-
	SLV 344	-
	SLV 345	-
	SLV 346	-
	SLV 347	-
	SLV 352	-
	SLV 356	-
	SLV354	-
	SLV357	-
	SLV359	-
	SLV360	-
	SOL02	-
	SPD473	-
	SPP200	pegmusirudin
	STG-A-MD	-
	STG-A-MD-4Ag	-
	STG-A-MD-4Ant	-
	STG-A-MDCHR	-
	STG-A-MDreh	-
	Sufentanil citrate	sufentanil citrate
	Survanta	beractant
	Synagis	palivizumab
	Synthroid	levothyroxine sodium
	Tadenan	pygeum africanum
	TAK-390MR	dexlansoprazole
	Tarka/Ocadrik	trandolapril & verapamil
	Tasidotin	tasidotin hydrochloride
	Tazicef	ceftazidime
	Teveten	eprosartan mesylate
	Teveten Plus	eprosartan mesylate & hydrochlorothiazide
	Thymone	thymone
	Thyrogen	thyrotropin alfa
	Tie-2 inhibitor	-
	TMX-67	febuxostat
	Tobramycin	tobramycin
	Tosuxacin	tosufloxacin tosylate
	Tracrium	atracurium besylate
	Tranxene	clorazepate dipotassium
	TriCor	fenofibrate
	TriCor & Crestor Combination	fenofibrate & rosuvastatin calcium
	TriCor (Micronized)	fenofibrate
	TriLipix	choline fenofibrate
	Trivalent Influenza vaccine	influenza vaccine
	TRPV1 Antagonists	-
	TRU-016	-
	TU 199	tenatoprazole
	Ultiva	remifentanil hydrochloride
	Ultravist	iopromide
	Uprima	apomorphine hydrochloride
	Urinary Incontinence Research Program	-
	Vancomycin	vancomycin monohydrochloride
	Veregen	polyphenon E
	vH1N1 Pandemic Vaccine	swine (H1N1) influenza vaccine
	VIA-2291	atreleuton
	Vicodin	acetaminophen & hydrocodone bitartrate
	Vicodin-CR	acetaminophen & hydrocodone bitartrate
	Vicoprofen	hydrocodone bitartrate & ibuprofen
	Viprinex	ancrod
	Vitamin K1	phytonadione
	VML 530	-
	Women's Health Research Project	-
	Wyeth Neuroscience Collaboration	-
	Xanax/Frontal	alprazolam
	Xience V	everolimus
	Xinlay	atrasentan
	Xopenex	levalbuterol hydrochloride
	Zamyl	sevirumab
	Zan-Extra	lercanidipine & enalapril
	Zanidip	lercanidipine
	Zemplar	paricalcitol
	ZEN-019	-
	Zileuton IV	zileuton
	Zoleptil	zotepine
	Zolip	fenofibrate & simvastatin
	ZoMaxx Drug-Eluting Stent	zotarolimus
	Zyflo	zileuton
	Zyflo CR	zileuton

2009 Product Sales analysis
2009 Pharmaceutical Sales
2009 Market Share & Global Ranking
Download to Excel
Search 2 yrs of company press releases


EP Vantage - last 6 months

Event - Meridia adcom debate primes pump for Lorqess decision (September 03, 2010)

Depomed avoids gabapentin lawsuit but road ahead remains rocky (August 04, 2010)

First half 2010 sees a return to more conventional deal values (July 28, 2010)

Which big pharma remains hostage to blockbuster fortune? (July 22, 2010)

Safety concerns narrow tanezumab’s potential further (July 21, 2010)

Displaying 5 out of a possible 24 unique stories.
Results Sorted By date
Display All Stories

Ranked on:
Annual Sales WW
2008

Group Total: Equals the sum of values in report based on report grouping.

Note: Where Top 5,10,100 etc filters have been applied, the aggregate value relates to the total of the original unfiltered group - not the displayed filtered data. Where n/a appears, a value has been hidden but is included in Group Total.

Examples:

e.g. Top 100 drugs reports. These are not grouped but are filtered to show only the top 100 products by sales in a particular year. The Group Total displayed is equal to the sum of all data within Evaluate Pharma - not just the top 100 products i.e. total market size.

e.g. Global Majors - Top 10 products. Report is grouped by Company and filtered to show only the top 10 products by sales in a particular year. Group Totals are displayed for each company and are equal to the sum of all available data for that company - not just the top 10 products.

XXXXXXX XXXXXXX:

XXXXXX: XXXX XX-X, XXXX X:
XX XXXX, XXXXXX, XXX XXXXXXXXX XXX X XXXXXXX XX XXXXXXXXXX XXXXXXXX, XXXXXX XXXXXX’X XXXX XXXXXXXXXX XXXXXXX XX XXX XXXXXXX. XX XXX XXXXXXXX XXX XXX XXXXXXXXX XX XXXXX’X XXXXXXX XXX XXXXXXX XXXXXXXX XX XXXXXXX XX XXX X.X. XXXXXX. XXXXX XXXXXXXX, XX’XX XXXXXXXX XXXXXX XXX XXX XXXXXXXXX XX XXXXXXXXX XX XXXX XXXXXX XXX XXX XXXXXX XXXXXX, XX XXXX XX XXX XXXXXXXX XXXXXXXXXX XXXXXXXXX XX XXX XXXXXX XXXXXX. XX XXXXXXXX XX XXXXXXX XXXXXX XXX XXXXXXXXXX XXXXXXX. XX XXXX XX XXXX XXXXXX’X XXXXXX XXX XXXXXXXX XXXXXX, XXXX XXXX, XX XXXXXXXXX XXXXXXXXXXXX XX XXX XXXXXXX XXXXXXX XXXXXXXXXX XXXX, XXX XXXXX-XX-XXXXXX XXXXXX XXXXXXXXXXXXX XXXXXXXXXXXXX XXXXX XX XXXXXX XXXX.

XXXX X:
XX XXXXX XXXX, XX XXXXXXXX XXX XXXXX XXX XXXXXXX XXXXXXXXXX XXX XXXXXX — XXXXXX XXXXXXXXX. XX XXXX, XX XXXXXXXX XXX XXXXXXXXX XXXXXXXXXX, XX XXXXXXXXX XXXXXXXXXXXX XX X XXXXX-XX-XXX-XXX XXXXXXXXXXXXX XXXXXXXX XX XXXXXX XXXX XXX XXXXXX XXX XXXXX XXXXXXXXX XX XXX XXXXXXXX.

XXXX XX:
XX XXXX, XXXXXX XXXXX XXX XXXXXXXXX XXXXXX XX XXXXXX XXX XXXXXXXXXX XXXXXXXXX, XXXXXXXX XX XXXXXXXX XXX XXXXX XXXXXXXXXX XXXXXXXXXXX, XXXXX XXXXXXXXX XXXXXX’X XXXXXXXXX XXXXX XX $X.X XXXXXXX XX XXXX XXXXXXXX XX $X.X XXXXXXX XX XXXX, XXX $X.X XXXXXXX XX XXXX. XXXXXXXXX XXX XXXXXX XX X XXXXX XXXXXXXXXX XX XXXX, XXXXXX XXXXXXXXX XXXXXXXXX XXXXXX XXXXX XX XXXXXXXXXXXXX $X XXXXXXX XX XXXX. XXXXXXXXXXX XXXXXXXX XXX XXXXXXXXXXX XXX XXXXXXX XXXXXXX XXX XXXX XXX XXXXXXXXX XX XX XXXXXXXXX XX XXXXXXXXXX XXX XXXXXXXXX.

XXXXXX: XXXX XXXXXX XXXXXX XXXX XX:
XXXXXXXXX XXXXX XXXXXX XX XXXXXX XXX XXXXXXXXX XXXXXX XXX XXXXX XXX XXXXXXXX XXXXXXXXX XXXXXXXX X.X. XXXXXXXXX XXXXX.

XXXXXX: XX XXXX XXXXXXX (XX XXX XXXX):
XXXXXX XXXXXXXX XXXX-XXXX XXXXXXXXX XXXXX XX XXXXXX XX $X XXXXXXX XX XXXX XXX XXX XXXXXXX XXXXXXXXX XXXXXX XXXXX XXX XXXXXX XX XXXXXXXXXXXXX $X XXXXXXX XX XXXX.

XXXXXXX XXX XXXXXXXX XXXXXX XX XXXXXXXX XX XX.X XXXXXXX, XXXXXX XXXXX XXXXXXXXX XX.X XXXXXXX XXXXXXXXXXXXXXX.

XXXXXXX XXXXXXX:

XXXXXX: XXXX XXXXXX XXXXXX, XXXX XX:
XXXXXXXXXX: XXXXXXXXX XXXXXXXXX XX XXXXXX XXXXXX XX XXXXXX’X XXXXXXXX XXX XXX XXXXXXXXX XX XX, XXXXXXX XXXXXX XXXXXXXXX, XXXXX’X XXXXXXX, XXXXXXXXX XXXXXXXXX, XXXXXXXXXX XXXXXXXXXXX XXX XXXXXXXXXXXXX XXXXXXXX XXXXXXXXXX XXXXXXXXX (XXX) — XXXXXXXXXX XXXXXXXXX XX XXXXX X XXXXX XXXXXXX, XXXXX XXXXXXXX XXXXXX (XXX), XXXXX X XXXX XX XXXXXXX XXXXXXXX. XXXXXX XX X XXXXX XXXXX XXXXXXXXXXX XXXXXXXXXX XXXXXXXX XXXX XXXXXX XXX XXXX’X XXXXXXXXXX XX XXX, XXXXXXXX XXX XXXXXXXXXXXX XXX XXXX XX XXX XXXXXXXXXXXXX XXXXXXXXXX XXXX XXXXX XXXXXXXX. XX XXXX, XX XXXXXXXX XXXXXX XXX XXX XXXXXXXXX XX XXX XXX XXXXXXXX — XXXXXXX XXXXXX XXXXXXXXX XXX XXX. XXXXXXXXX XXXXXXXX XXX XXXXX XXXXXXX XXX XXXXXXXXXXXXX XX XXXX XXX, XXXXX XXXXX XX XXXX. XXXXXXXXX XXXXXXX XX XXXXXXXXX XXX XXXXXXX XXXXXX XXXXXXXXX. XXX XXXXXXXX XX XXX XXXXXXX XXXXXX XXXX XXXXXX XX XXXXXX, XXXX XXXXXXXXXXXXX XX XXXXXXX XX XXXXXX XXXX XXXXXXXXX XXXXXXXXXXXX XXXXXXXX XX XXXXXX XXXXXXX. XXXXXX XX XXXX XXXX XX XXXXX XX XXX XXX, XXXXXXX XXXXXXXX XXXX XXX XXXX XX XXXXXX XX XXX XXXXXX XXX XXXXXX X XXXXXXX’X XXXXXXX XX XXXXXXX XXXXX XXXXXXXXXX; XXXXX’X XXXXXXX, XXXXXXXXXXXXX XX XXXXXXXXXXXX XX XXX XXXXXXXXXXXXXXXX XXXXX; XXXXXXXXX XXXXXXXXX, XXXXXXXXXXXXX XX XXXX XXXXXXXXX XXX XXXXXXXXX XXXX XXXXXXX; XXX XXXXXXXXXX XXXXXXXXXXX, XX XXXXXXXXXXXX XX XXX XXXXX XXXX XXX XXXXXX XX XXXXXXXX XX XXXXX XXXX XXX XXXXXXXX XXXXXXXXXX. XX XXXXX, XX XXXXXXXX XXXXXX XXX XX XXX XXXXXXXXX X XXXXXXXXXX XXXXXXXXXXX XXX XXXXXXX XXXXXX XXXXXXXXX. XXXXXX XX XXXX XX XXXXXXXXXXX XXX XXXXXXXXXX XXXXXXX (XXXXXXXXXXXX XX XXX XXXXX XXXXXXXXX) XXX XXXXXXXXX XXXXX’X XXXXXXX. XXXX XXXXXXXXX XX XXXXXXXX XXXXXXXXXX XXXXXXXX XX X XXXXXX, XXXX-XXXXXXXXXXX XXXXXXX, XXXXXX XXXXXX XXXXXXXX XX XX XXXX XX XXXXX XXXXXXXX XX XXXXXXXXX XX XXXXXXXX XXX XXXXX XX XXXX.

XXXXXX: XXXX XX-X, XXXX XX:
XXXXXX XXXXX XXX XXXXXXXXX XXXXXX XX XXXXXX XXX XXXXXXXXXX XXXXXXXXX, XXXXXXXX XX XXXXXXXX XXX XXXX XXXXXXXXXX XXXXXXXXXXX, XXXXX XXXXXXXXX XXXXXX'X XXXXXXXXX XXXXX XX $X.X XXXXXXX XX XXXX XXXXXXXX XX $X.X XXXXXXX XX XXXX, XXX $X.X XXXXXXX XX XXXX. XXXXXX XXXXXXXXX XXXXXXXXX XXXXXX XXXXX XX XXXXXXXX XXXX XXXX XX XXXXXXX XX XXXX. XXXXXX XX XXXXXXXX XXX XXXXXXXXXX XXXXXXXXXXX XXX XXXXXX. XXXXXXXXXXX XXXXXXXX XXX XXXXXXXXXXX XXX XXXXXXX XXXXXXX XXX XXXX XXX XXXXXXXXX XX XX XXXXXXXXX XX XXXXXXXXXX XXX XXXXXXXXX XXXXXXXXX XX XXXXXX.

XXXX, XX:
XXXXXXXXX XXXXX XX XXXXXX XXX XXX XXXXXXXX XXXXXXXX XXXXX XX XXXX XXXXXXXXX XXX XXX XXXXXXXX XX XXX XXXXX XXXXXXXX XXX X.X. XXXXXXXXX XXXXXXXX XX XXXX.

XXXXXX: XX XXXX XXXXXXX (XX XXX XXXX):
XXXXXXX XXX XXXXXXXX XXXXXX XX XXXXXXXX XX X.X XXXXXXX, XXXXXX XXXXX XXXXXXXXX XX.X XXXXXXX XXXXXXXXXXXXXXX.
XXXXXXXXX XXXXXXXXXXXXXX XXXXX XXXXXXXXX XXXXXX XX XXXXXXX XXXXXX XX XXXXXX-XXXXX XXXXXX XX XXXXXX®, XXXXXXX®, XXX XXX XXXXXX®/XXXXXXXX™ XXXXXXXXX. XXXXXX XXXXXX XXXXX XX XXX XXXX XXXX XXXX XXXX XXXX $X.X XXXXXXX. XXXXXXXXXXXXX XXXXXX XXX XXXXXX XX XXXXXX, XXXXX XXXXXXXXX XXXX XXXX XX XXXXXXX, XXX XXX XX XXXXXX XX XXXXXXX XXXXXXXXX XXX XXXXXXXX XXXXXX XX XXXXXXX XXXXXXXX, XXXXXXXXXX XXXX XXX XXXXXXXXXXX XX XXXXXXXX XXXXXXXX. XXXXXXX XXXXX XXXX XXXXXXXXXXX XX XXXXXX XX XXX XXXXXXX, XXXXXX XX XXXXXXXXX XXXXXXX XX XXX XXXXXX XXXXXX XX XXXXXXXXXXXXX XXXXXXX.

XXXXXXX XXXXXXX:

XXXXXX: XXXX XXXXXX XXXXXX, XXXX XX:
XXXXXXX XXXXXXX X XXXXXXX XXXXXXXX XXXXXXXXX XXX XXX. XXXXX, XXX XXX XX XXXXXXX XX X XXXXXXX XXXXXXX, XXXXXX XXXX-XXXX XXXXX XXXXXXXXXXX, XXXXXXXXXXXX XXX XXXXXXXXXXX XXXXXXXXX XXX XXXXXXX XXXXXXX. XXXXXXX XXX XXXXXX XXXXXXXXXX XXXX, XXXXX XXXXXXXXX X XXX XXXXX XX XXXXXXXXXX XXX XXXXXXXX XXX XX XXXXXXX. XXXX XX XXXXXXXXX XXXXXXX XXXXXXXXXX — XXXX XXX XXXXX XX XX XXXXXX XXXXXXXXX XX X XXXX — XX XXX XXXXXXX XXXXX XX XXX XXXXXXXXX XXXXXXX. XX XXXX, XXXXXX XXXXXXXX X XXX, XXXXX-XXXXXXXX XXXXXXX XXXXXX, XXXXX XX XXXX XXXXXXXX XXX XXX XX XXXXXXXX XXXX XXX.

XXXXXX: XX XXXX XXXXXXX (XX XXX XXXX):
XXXXXXX XXX XXXXXXXX XXXXXX XX XXXXXXXX XX X.X XXXXXXX, XXXXXXX XXXXX XXXXXXXXX XX.X XXXXXXX XXXXXXXXXXXXXXX.

XXXXXXX XXXXXXX:

XXXXXX: XX XXXX XXXXXXX (XX XXX XXXX):
XXXXXXX XXX XXXXXXXX XXXXXX XX XXXXXXXX XX X.X XXXXXXX, XXXXXXX XXXXX XXXXXXXXX XX.X XXXXXXX XXXXXXXXXXXXXXX. XXXXXXXXXXXXX XXXXXX XXX XXXXXX XX XXXXXX, XXXXX XXXXXXXXX XXXX XXXX XX XXXXXXX, XXX XXX XX XXXXXX XX XXXXXXX XXXXXXXXX XXX XXXXXXXX XXXXXX XX XXXXXXX XXXXXXXX, XXXXXXXXXX XXXX XXX XXXXXXXXXXX XX XXXXXXXX XXXXXXXX. XXXXXXX XXXXX XXXX XXXXXXXXXXX XX XXXXXX XX XXX XXXXXXX, XXXXXX XX XXXXXXXXX XXXXXXX XX XXX XXXXXX XXXXXX XX XXXXXXXXXXXXX XXXXXXX.

XXXXXXX XXXXXXXXX XXXXXXXXXXX XXXXXXX:

XXXXXX: XXXXXX XXXXXX, XXXX XX :
XX XXXX, XX XXXXXX, XXXXXX XXXXXXXX X XXX, XXXXX-XXXXXXXX XXXXXXX XXXXXX, XXX XXXXX XXX XXXX XXXXXXXXXXXX XXXXXXXX XXXXXXXXX XXXXXX XXXXXXXX XXX XXX XX XXXXXXXX XXXX XXX.

XXXXXXX XXXXXXX:

XXXXXX: XXXX XXXXXX XXXXXX, XXXX XX:
XXXXXXXXX XXXXX XXXXXX XX XXXXXX XXX XXXXXXXXX XXXXXX XXX XXXXX XXX XXXXXXXX XXXXXXXXX XXXXXXXX X.X. XXXXXXXXX XXXXX.

XXXX XX:
X.X. XXXXX XX XXXXXXXX XXXX $X.X XXXXXXX XX XXXX.

XXXXXXX XXXXXXX:

XXXXXX: XXXX XX-X, XXXX XX:
XXXXXX XXX XXXX XXXXXXX XXXXXXXXXXX XXXXX XX XXX XXXXXX XXXX XX XXXX XXX XXXXXXXX , XXXXX XXX X.X. XXXXX XX $X.X XXXXXXX XX XXXX.

Shaded Cells

A shaded cell signifies potentially incomplete data. E.g. A shaded cell in "Change (+/-)" means there is no corresponding value, i.e. there is data for 2001, but no data for 2000. This could signify a product launch, first time disclosure of sales, a product acquisition or missing data.

A shaded cell containing n/a signifies valid data followed by blank or zero values. E.g. A shaded cell containing n/a in "Change (+/-)" means a value is present for 2000, but blank for 2001. This could signify a product disposal / withdrawal, discontinuation of disclosure or missing data.

XXXXXXXX:
X) +XXXX XXXXXX XXXXX - XX.
X) +XXXX XXXXXXXXXXXXX XXXXXXXXXXXXXXX XXXXX.
X) XXX XXXXXXXXXXXX.

XXXXXXXX:
X) +XXXX XXXXXX XXXXX - XX
X) +XXXX XXXXXXXXXXXXX XXXXXXXXXXXXXXX XXXXX.
X) +XXX.XXX XXX (XX XX X XXX XXXX).

XXXXXXXX XXX XXXXXXXXXXXXXX XXXXXXXX XX XX X XXX XXXX.